US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 12.430
  • +0.120+0.97%
Close Oct 18 16:00 ET
  • 12.430
  • 0.0000.00%
Post 16:04 ET
711.82MMarket Cap-6093P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
55.22%33.53M
16.00%34.34M
-1.89%104.96M
11.75%30.42M
0.52%23.34M
-35.12%21.6M
27.30%29.6M
49.65%106.99M
25.10%27.22M
30.74%23.22M
Selling and administrative expenses
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
6.80%5.6M
-General and administrative expense
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
6.80%5.6M
Research and development costs
61.82%29.11M
30.92%29.88M
4.70%86.14M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
42.58%22.83M
61.01%82.27M
35.11%21.58M
40.76%17.63M
Operating profit
-55.22%-33.53M
-16.00%-34.34M
1.89%-104.96M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.6M
-27.30%-29.6M
-49.65%-106.99M
-25.10%-27.22M
-30.74%-23.22M
Net non-operating interest income expense
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
492.38%622K
Non-operating interest income
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
492.38%622K
Other net income (expense)
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
-114.29%-120K
Other non- operating income (expenses)
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
-114.29%-120K
Income before tax
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
Income tax
Net income
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
Net income continuous Operations
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
Minority interest income
Net income attributable to the parent company
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
Basic earnings per share
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
-26.67%-0.57
Diluted earnings per share
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
-26.67%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 55.22%33.53M16.00%34.34M-1.89%104.96M11.75%30.42M0.52%23.34M-35.12%21.6M27.30%29.6M49.65%106.99M25.10%27.22M30.74%23.22M
Selling and administrative expenses 22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M6.80%5.6M
-General and administrative expense 22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M6.80%5.6M
Research and development costs 61.82%29.11M30.92%29.88M4.70%86.14M19.87%25.87M10.36%19.45M-33.51%17.99M42.58%22.83M61.01%82.27M35.11%21.58M40.76%17.63M
Operating profit -55.22%-33.53M-16.00%-34.34M1.89%-104.96M-11.75%-30.42M-0.52%-23.34M35.12%-21.6M-27.30%-29.6M-49.65%-106.99M-25.10%-27.22M-30.74%-23.22M
Net non-operating interest income expense 100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K492.38%622K
Non-operating interest income 100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K492.38%622K
Other net income (expense) 190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K-114.29%-120K
Other non- operating income (expenses) 190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K-114.29%-120K
Income before tax -51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M
Income tax
Net income -51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M
Net income continuous Operations -51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M
Minority interest income
Net income attributable to the parent company -51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M
Basic earnings per share -10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65-26.67%-0.57
Diluted earnings per share -10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65-26.67%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data